Sitaxentan [Thelin] to be withdrawn from market worldwide due to cases of unpredictable serious liver injury
December 13, 2010 – We learn today that the European Medicines Agency (EMEA) has been informed of Pfizer’s decision to voluntarily withdraw Sitaxentan [Thelin] from the market worldwide further to new information on two cases of fatal liver injury. Pfizer …